Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era
Authors
Keywords
Kidney cancer, Targeted therapy, Metastatic, Cancer-specific mortality, Competing risks analysis
Journal
INTERNATIONAL UROLOGY AND NEPHROLOGY
Volume 49, Issue 12, Pages 2143-2149
Publisher
Springer Nature
Online
2017-09-20
DOI
10.1007/s11255-017-1703-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma
- (2017) Sergio Fernández-Pello et al. EUROPEAN UROLOGY
- Clinical correlates and prognostic value of different metastatic sites in metastatic renal cell carcinoma
- (2017) Omar Abdel-Rahman Future Oncology
- Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
- (2016) Toni K Choueiri et al. LANCET ONCOLOGY
- Precision oncology: identifying predictive biomarkers for the treatment of metastatic renal cell carcinoma
- (2016) Parth K. Modi et al. Translational Cancer Research
- Systemic Therapy for Non–clear Cell Renal Cell Carcinomas: A Systematic Review and Meta-analysis
- (2015) Francisco E. Vera-Badillo et al. EUROPEAN UROLOGY
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends in Metastatic Kidney Cancer Survival From the Cytokine to the Targeted Therapy Era
- (2015) Liam C. Macleod et al. UROLOGY
- Survival among patients with advanced renal cell carcinoma in the pretargeted versus targeted therapy eras
- (2015) Pengxiang Li et al. Cancer Medicine
- Assessing the accuracy and generalizability of the preoperative and postoperative Karakiewicz nomograms for renal cell carcinoma: results from a multicentre European and US study
- (2013) Luca Cindolo et al. BJU INTERNATIONAL
- The Effect of Targeted Therapy on Overall Survival in Advanced Renal Cancer: A Study of the National Surveillance Epidemiology and End Results Registry Database
- (2013) Ulka Vaishampayan et al. Clinical Genitourinary Cancer
- Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial
- (2013) Robert J Motzer et al. LANCET ONCOLOGY
- Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
- (2013) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Disease-Specific Survival in De Novo Metastatic Renal Cell Carcinoma in the Cytokine and Targeted Therapy Era
- (2013) Sumanta K. Pal et al. PLoS One
- Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program
- (2013) Brian Shuch et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Effect of number and location of distant metastases on renal cell carcinoma mortality in candidates for cytoreductive nephrectomy: Implications for multimodal therapy
- (2012) Umberto Capitanio et al. INTERNATIONAL JOURNAL OF UROLOGY
- Non-clear cell advanced kidney cancer
- (2010) Pedro Sánchez et al. ANTI-CANCER DRUGS
- Regression modeling of competing risk using R: an in depth guide for clinicians
- (2010) L Scrucca et al. BONE MARROW TRANSPLANTATION
- Phase 3 trial of everolimus for metastatic renal cell carcinoma
- (2010) Robert J. Motzer et al. CANCER
- Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival
- (2010) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- A Proposal for Reclassification of the Fuhrman Grading System in Patients with Clear Cell Renal Cell Carcinoma
- (2009) Maxine Sun et al. EUROPEAN UROLOGY
- Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
- (2009) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- (2009) Daniel Y.C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now